Literature DB >> 25125346

May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease?

Emilio Fernández1, José-Manuel García-Moreno, Angel Martín de Pablos, José Chacón.   

Abstract

The research group has detected nitrosative stress and a singular version of nitrosylated serum α-synuclein in serum of Parkinson's disease (PD) patients. Dysfunction of the thyroid gland has been proposed to be linked to this disease. The aim of the study was to know if the thyroid gland is involved in idiopathic PD and nitrosative stress. We studied 50 patients (early and advanced disease patients), 35 controls, and 6 subjects with thyroidectomy. Clinical characteristics, serum thyroperoxidase levels, and 3-nitrotyrosine proteins were analyzed. Enzyme-linked immunosorbent assay and immunoblotting methods were employed. The findings indicated that the prevalence of two thyroid dysfunctions (hyper- or hypothyroidism) was not found to be different in patients relative to controls. However, the levels of the enzyme thyroperoxidase were found to be elevated in early disease patients (p<0.006), not in advanced disease subjects, and these levels were negatively correlated with serum 3-nitrotyrosine proteins (p<0.05), the indicators of nitrosative stress. The thyroidectomized subjects showed very low levels of serum 3-nitrotyrosine proteins (78% reduction vs. controls) and, among these proteins, the nitrosylated serum α-synuclein was nearly absent. These observations lead to the hypothesis that the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and they could influence Parkinsonian nitrosative stress as well as nitrosylation of serum α-synuclein, a potentially pathogenic factor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25125346      PMCID: PMC4215330          DOI: 10.1089/ars.2014.6072

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

1.  Subclinical thyroid disease in patients with Parkinson's disease.

Authors:  H Tandeter; A Levy; G Gutman; P Shvartzman
Journal:  Arch Gerontol Geriatr       Date:  2001 Nov-Dec       Impact factor: 3.250

2.  [Hypothyroidism concealed by Parkinson's disease].

Authors:  J M García-Moreno; J Chacón
Journal:  Rev Neurol       Date:  2002 Oct 16-31       Impact factor: 0.870

3.  May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic Parkinson's disease?

Authors:  Emilio Fernández; José-Manuel García-Moreno; Angel Martín de Pablos; José Chacón
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

4.  Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure.

Authors:  Dnyanesh N Tipre; David S Goldstein
Journal:  J Nucl Med       Date:  2005-11       Impact factor: 10.057

5.  Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.

Authors:  Hideaki Matsui; Fukashi Udaka; Masaya Oda; Akiko Tamura; Tamotsu Kubori; Kazuto Nishinaka; Masakuni Kameyama
Journal:  Ann Nucl Med       Date:  2005-05       Impact factor: 2.668

6.  Nitric oxide/cGMP signaling inhibits TSH-stimulated iodide uptake and expression of thyroid peroxidase and thyroglobulin mRNA in FRTL-5 thyroid cells.

Authors:  Leonardo Gabriel Bazzara; María Laura Vélez; María Eugenia Costamagna; Ana María Cabanillas; Laura Fozzatti; Ariel Maximiliano Lucero; Claudia Gabriela Pellizas; Ana María Masini-Repiso
Journal:  Thyroid       Date:  2007-08       Impact factor: 6.568

7.  May serum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson's disease?

Authors:  José-Manuel García-Moreno; Angel Martín de Pablos; María-Isabel García-Sánchez; Carolina Méndez-Lucena; Fátima Damas-Hermoso; Macarena Rus; José Chacón; Emilio Fernández
Journal:  Antioxid Redox Signal       Date:  2012-12-07       Impact factor: 8.401

8.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

  8 in total
  3 in total

Review 1.  The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?

Authors:  Tianfang Jiang; Gen Li; Jun Xu; Shane Gao; Xu Chen
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

2.  SUMOylation of Alpha-Synuclein Influences on Alpha-Synuclein Aggregation Induced by Methamphetamine.

Authors:  Lin-Nan Zhu; Hong-Hua Qiao; Ling Chen; Le-Ping Sun; Jia-Liang Hui; Yong-Ling Lian; Wei-Bing Xie; Jiu-Yang Ding; Yun-le Meng; Bo-Feng Zhu; Ping-Ming Qiu
Journal:  Front Cell Neurosci       Date:  2018-08-24       Impact factor: 5.505

Review 3.  Association of Oxidative Stress on Pregnancy.

Authors:  Kinga Toboła-Wróbel; Marek Pietryga; Piotr Dydowicz; Marta Napierała; Jacek Brązert; Ewa Florek
Journal:  Oxid Med Cell Longev       Date:  2020-09-15       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.